# CYP21A2

## Overview
The CYP21A2 gene encodes the enzyme 21-hydroxylase, a member of the cytochrome P450 superfamily, which is integral to the biosynthesis of steroid hormones. This enzyme, categorized as a monooxygenase, is primarily involved in the 21-hydroxylation of steroid precursors, a critical step in the production of glucocorticoids and mineralocorticoids. These hormones are essential for various physiological processes, including metabolism regulation, immune response, and maintenance of blood pressure and electrolyte balance (Neunzig2017The; Torres2003Phenotype). The CYP21A2 gene is located on chromosome 6p21.3, within the major histocompatibility complex (MHC) region, and mutations in this gene are the most common cause of congenital adrenal hyperplasia (CAH), a disorder characterized by impaired cortisol synthesis and excess androgen production (Concolino2009Two; Speiser2010Congenital). Understanding the structure and function of the CYP21A2 gene and its encoded enzyme is crucial for elucidating the pathophysiology of CAH and developing targeted therapeutic strategies.

## Structure
The CYP21A2 gene encodes the enzyme 21-hydroxylase, a member of the cytochrome P450 superfamily, which is crucial for steroid biosynthesis. The primary structure of the enzyme consists of 495 amino acids (Cohen2020In). Its secondary structure includes 13 alpha helices and 9 beta strands, organized around a central heme group, which is essential for its catalytic activity (Cohen2020In). The tertiary structure forms a compact, globular shape, with the heme-binding domain being a critical feature for its function (Janner2006Clinical). 

The enzyme is located in the endoplasmic reticulum membrane and relies on NADPH-dependent P450 oxidoreductase for electron transfer, highlighting its role in the electron transport chain (Bruque2016Structurebased). The protein structure has been modeled using templates such as rabbit P4502C5 and human CYP17A1, with energy minimization and molecular dynamics used to refine the model (Mizrachi2011Why). 

Mutations in CYP21A2 can lead to structural destabilization, affecting protein stability and function, as seen in various studies using molecular dynamics simulations and structural modeling (Dubey2009A; Cohen2020In). These structural insights are crucial for understanding the enzyme's role in congenital adrenal hyperplasia (CAH) and other related disorders.

## Function
The CYP21A2 gene encodes the enzyme 21-hydroxylase, a member of the cytochrome P450 family, which plays a crucial role in steroidogenesis within the adrenal cortex. This enzyme is responsible for the 21-hydroxylation of steroid precursors, specifically converting progesterone and 17α-hydroxyprogesterone into 11-deoxycorticosterone and 11-deoxycortisol, respectively. These conversions are essential steps in the biosynthesis of glucocorticoids and mineralocorticoids, hormones vital for regulating metabolism, immune response, blood pressure, and electrolyte balance (Neunzig2017The; Torres2003Phenotype).

CYP21A2 is located in the endoplasmic reticulum of adrenal cortex cells, where it facilitates the production of cortisol and aldosterone, hormones critical for maintaining homeostasis in response to stress and for controlling salt and water balance in the body (Concolino2009Two). The enzyme's activity is tightly regulated, and its function is crucial for normal physiological processes. Mutations in the CYP21A2 gene can lead to 21-hydroxylase deficiency, the most common cause of congenital adrenal hyperplasia, a disorder characterized by impaired hormone production and altered steroid metabolism (White1985Two; TusieLuna1990Determination).

## Clinical Significance
Mutations in the CYP21A2 gene are the primary cause of congenital adrenal hyperplasia (CAH), a group of autosomal recessive disorders characterized by impaired cortisol synthesis. This deficiency leads to an accumulation of cortisol precursors, which are diverted to sex hormone biosynthesis, resulting in androgen excess (Speiser2010Congenital). CAH is classified into classic and non-classic forms. The classic form includes salt-wasting (SW) and simple virilizing (SV) types, with the former involving severe aldosterone deficiency leading to salt loss and hypovolemia (Speiser2010Congenital). Non-classic CAH (NCCAH) is more prevalent and often asymptomatic, though it can present with signs of androgen excess such as early adrenarche and precocious puberty (Sumińska2020NonClassic).

The severity of CAH correlates with specific CYP21A2 mutations. Large deletions and a splicing mutation account for about 50% of classic CAH alleles, while a point mutation in exon 7 is common in NCCAH (Speiser2010Congenital). Genotype-phenotype correlations are generally strong for non-classic CAH mutations but are less reliable for simple virilizing CAH mutations, particularly with the p.I172N mutation (Finkielstain2011Comprehensive). The presence of CYP21A2 duplications in some individuals may offer protection against CAH if a de novo mutation occurs (Finkielstain2011Comprehensive).

## Interactions
CYP21A2, a crucial enzyme in steroid biosynthesis, interacts with several proteins to perform its function. One significant interaction is with cytochrome P450 reductase (CPR), which provides the necessary electrons for CYP21A2's catalytic activity. This interaction is essential for the enzyme's role in converting progesterone and 17α-hydroxyprogesterone into their hydroxylated products (Janner2006Clinical; Neunzig2017The).

CYP21A2 also interacts with the chaperone proteins GroEL and GroES during its expression and purification in E. coli, which aids in proper protein folding and stability (Neunzig2017The). These chaperones are co-expressed with CYP21A2 to enhance its functional expression in bacterial systems.

Additionally, CYP21A2 has been shown to interact with the aromatase enzyme CYP19A1. The steroid metabolite 16(β)-hydroxy-androstenedione (16bOHA4), produced by CYP21A2, serves as a substrate for CYP19A1. This interaction highlights a novel metabolic pathway where 16bOHA4 is further metabolized by CYP19A1, although with decreased catalytic efficiency compared to other substrates (Neunzig2017The). These interactions underscore the enzyme's role in complex steroidogenic pathways and its potential implications in various physiological and pathological conditions.


## References


[1. (Bruque2016Structurebased) Carlos D. Bruque, Marisol Delea, Cecilia S. Fernández, Juan V. Orza, Melisa Taboas, Noemí Buzzalino, Lucía D. Espeche, Andrea Solari, Verónica Luccerini, Liliana Alba, Alejandro D. Nadra, and Liliana Dain. Structure-based activity prediction of cyp21a2 stability variants: a survey of available gene variations. Scientific Reports, December 2016. URL: http://dx.doi.org/10.1038/srep39082, doi:10.1038/srep39082. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep39082)

[2. (Janner2006Clinical) Marco Janner, Amit V Pandey, Primus E Mullis, and Christa E Flück. Clinical and biochemical description of a novel cyp21a2 gene mutation 962_963insa using a new 3d model for the p450c21 protein. European Journal of Endocrinology, 155(1):143–151, July 2006. URL: http://dx.doi.org/10.1530/eje.1.02172, doi:10.1530/eje.1.02172. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1530/eje.1.02172)

[3. (Mizrachi2011Why) Dario Mizrachi, Zhu Wang, Kamalesh K. Sharma, Manisha K. Gupta, Keliang Xu, Christopher R. Dwyer, and Richard J. Auchus. Why human cytochrome p450c21 is a progesterone 21-hydroxylase. Biochemistry, 50(19):3968–3974, April 2011. URL: http://dx.doi.org/10.1021/bi102078e, doi:10.1021/bi102078e. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi102078e)

[4. (Torres2003Phenotype) N. Torres, M.P. Mello, C.M.R. Germano, L.L.K. Elias, A.C. Moreira, and M. Castro. Phenotype and genotype correlation of the microconversion from the cyp21a1p to the cyp21a2 gene in congenital adrenal hyperplasia. Brazilian Journal of Medical and Biological Research, 36(10):1311–1318, October 2003. URL: http://dx.doi.org/10.1590/s0100-879x2003001000006, doi:10.1590/s0100-879x2003001000006. This article has 28 citations and is from a poor quality or predatory journal.](https://doi.org/10.1590/s0100-879x2003001000006)

[5. (Dubey2009A) Sudhisha Dubey, Susan Idicula-Thomas, Mohammad Anwaruddin, Chinnaraj Saravanan, R Raveendra Varma, and Anurupa Maitra. A novel 9-bp insertion detected in steroid 21-hydroxylase gene (cyp21a2): prediction of its structural and functional implications by computational methods. Journal of Biomedical Science, 16(1):3, 2009. URL: http://dx.doi.org/10.1186/1423-0127-16-3, doi:10.1186/1423-0127-16-3. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/1423-0127-16-3)

[6. (White1985Two) P C White, D Grossberger, B J Onufer, D D Chaplin, M I New, B Dupont, and J L Strominger. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proceedings of the National Academy of Sciences, 82(4):1089–1093, February 1985. URL: http://dx.doi.org/10.1073/pnas.82.4.1089, doi:10.1073/pnas.82.4.1089. This article has 293 citations.](https://doi.org/10.1073/pnas.82.4.1089)

[7. (Cohen2020In) Michal Cohen, Emanuele Pignatti, Monica Dines, Adi Mory, Nina Ekhilevitch, Rachel Kolodny, Christa E. Flück, and Dov Tiosano. In silico structural and biochemical functional analysis of a novel cyp21a2 pathogenic variant. International Journal of Molecular Sciences, 21(16):5857, August 2020. URL: http://dx.doi.org/10.3390/ijms21165857, doi:10.3390/ijms21165857. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21165857)

[8. (Sumińska2020NonClassic) Marta Sumińska, Klaudia Bogusz-Górna, Dominika Wegner, and Marta Fichna. Non-classic disorder of adrenal steroidogenesis and clinical dilemmas in 21-hydroxylase deficiency combined with backdoor androgen pathway. mini-review and case report. International Journal of Molecular Sciences, 21(13):4622, June 2020. URL: http://dx.doi.org/10.3390/ijms21134622, doi:10.3390/ijms21134622. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21134622)

[9. (Neunzig2017The) J. Neunzig, M. Milhim, L. Schiffer, Y. Khatri, J. Zapp, A. Sánchez-Guijo, M.F. Hartmann, S.A. Wudy, and R. Bernhardt. The steroid metabolite 16(β)-oh-androstenedione generated by cyp21a2 serves as a substrate for cyp19a1. The Journal of Steroid Biochemistry and Molecular Biology, 167:182–191, March 2017. URL: http://dx.doi.org/10.1016/j.jsbmb.2017.01.002, doi:10.1016/j.jsbmb.2017.01.002. This article has 19 citations.](https://doi.org/10.1016/j.jsbmb.2017.01.002)

[10. (TusieLuna1990Determination) M T Tusie-Luna, P Traktman, and P C White. Determination of functional effects of mutations in the steroid 21-hydroxylase gene (cyp21) using recombinant vaccinia virus. Journal of Biological Chemistry, 265(34):20916–20922, December 1990. URL: http://dx.doi.org/10.1016/s0021-9258(17)45304-x, doi:10.1016/s0021-9258(17)45304-x. This article has 174 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)45304-x)

[11. (Concolino2009Two) Paola Concolino, Francesca Vendittelli, Enrica Mello, Cristiana Carelli Alinovi, Angelo Minucci, Cinzia Carrozza, Stefano Angelo Santini, Cecilia Zuppi, and Ettore Capoluongo. Two novel cyp21a2 missense mutations in italian patients with 21‐hydroxylase deficiency: identification and functional characterisation. IUBMB Life, 61(3):229–235, January 2009. URL: http://dx.doi.org/10.1002/iub.147, doi:10.1002/iub.147. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/iub.147)

[12. (Speiser2010Congenital) Phyllis W. Speiser, Ricardo Azziz, Laurence S. Baskin, Lucia Ghizzoni, Terry W. Hensle, Deborah P. Merke, Heino F. L. Meyer-Bahlburg, Walter L. Miller, Victor M. Montori, Sharon E. Oberfield, Martin Ritzen, and Perrin C. White. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology &amp; Metabolism, 95(9):4133–4160, September 2010. URL: http://dx.doi.org/10.1210/jc.2009-2631, doi:10.1210/jc.2009-2631. This article has 798 citations.](https://doi.org/10.1210/jc.2009-2631)

[13. (Finkielstain2011Comprehensive) Gabriela P. Finkielstain, Wuyan Chen, Sneha P. Mehta, Frank K. Fujimura, Reem M. Hanna, Carol Van Ryzin, Nazli B. McDonnell, and Deborah P. Merke. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The Journal of Clinical Endocrinology &amp; Metabolism, 96(1):E161–E172, January 2011. URL: http://dx.doi.org/10.1210/jc.2010-0319, doi:10.1210/jc.2010-0319. This article has 139 citations.](https://doi.org/10.1210/jc.2010-0319)